
Collaboration - November 4, 2013
Otsuka named as Lundbeck’s partner in Japan on Nalmefene
Danish Lundbeck and Japanese Otsuka Pharmaceutical have announced that the companies’ existing alliance now also includes the development and commercialization of Nalmefene in Japan. Under the terms of the agreement, Lundbeck will receive an initial payment of EUR 50 million from Otsuka upon signing. Lundbeck will finance the development costs and has an option to […]